TRANSGENEBIOTEK- potential untapped....

I have been recommending this stock for INVESTMENT buying ever since I saw the growth in the sales from mere 0.5 cr to 5 cr in a quarter. This has been happening for the last 4-5 quarters. I am blindly supporting the stock from Rs 26-30 levels but the stock fell relentlessly from there to Rs 8-9 range. Where as the products pipeline has the opportunity to out perform is not happening in the bourses. The equity has grossly bloated from 15 cr to 65 cr with in two years (2010-12).  

BSE- Notices for refernece:

Notice No	20110505-20	Notice Date	05 May 2011
Category	Company related	Segment	Equity
Subject	Listing of new securities of Transgene Biotek Ltd.
Content
Trading members of the Exchange are hereby informed that the under mentioned securities of Transgene Biotek Ltd, (Scrip Code: 526139, ISIN No INE773D01018) are listed and admitted for trading on the Exchange with effect from Friday, May 06, 2011. Security Details 2,50,00,000 equity shares of Rs.10/- each issued underlying  Global Depository Receipts (1GDR = 10 Equity Shares) of the Company. These shares are ranking pari passu with the existing equity shares of the company. Date of Allotment 22.02.2011 Dist. Nos. 15770001 to 40770000 Price per GDR US $ 9.2 In case trading members require any clarification on the subject matter of the notice, they may please contact the undersigned on Tel. Nos. 022 2272 8899. (Pavan V. Naik) Deputy Manager - Dept. of Corporate Services